Age, frailty and diabetes – triple jeopardy for vulnerability to COVID-19 infection
Open Access
- 23 April 2020
- journal article
- editorial
- Published by Elsevier BV in EClinicalMedicine
- Vol. 22, 100343
- https://doi.org/10.1016/j.eclinm.2020.100343
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- Coronavirus Disease 2019–COVID-19Clinical Microbiology Reviews, 2020
- Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, ChinaJAMA Internal Medicine, 2020
- Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, ChinaJama-Journal Of The American Medical Association, 2020
- Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysisInternational Journal of Infectious Diseases, 2020
- Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort studyThe Lancet, 2020
- Diabetes and global ageing among 65–99-year-old adults: Findings from the International Diabetes Federation Diabetes Atlas, 9th editionDiabetes Research and Clinical Practice, 2020
- Frailty and sarcopenia - newly emerging and high impact complications of diabetesJournal of Diabetes and its Complications, 2017
- Predictors of viral pneumonia: The need for viral testing in all patients hospitalized for nursing home‐acquired pneumoniaGeriatrics & Gerontology International, 2013
- Frailty is associated with impairment of vaccine-induced antibody response and increase in post-vaccination influenza infection in community-dwelling older adultsVaccine, 2011